The IP & Science business of Thomson Reuters, the world’s leading provider of intelligent information for businesses and professionals, released a white paper, “Managing Scholarly Meetings: Best Practices for Best-In-Class Proceedings,” detailing how ScholarOne AbstractsTM and meeting solutions can be used to streamline the efficiency of scholarly meeting planning and management.

Five of the top tips for scholarly meeting management across the preliminary, procedural and post-meeting phases of a conference are:

1. Use your management system to create a detailed project plan for the course of your meeting – this makes it easier to stick to deadlines and accommodate changes after deadlines

2. Collect author information as early as possible and track it in the management system, including audio-visual needs, recording permissions, copyrights, etc.
3. Utilize your abstract management system to schedule virtual planning sessions, saving time and money over in-person meetings

4. Manage all aspects of the abstract review process in your workflow management system, creating the ability for reviewers to move incorrectly categorized abstracts and easily manage the moving parts of the process

5. Create a multimedia archive of the meeting material by archiving abstracts, presentation slides, recordings and more

The full list of tips and best practices can be accessed in the white paper “Managing Scholarly Meetings: Best Practices for Best-In-Class Proceedings”.

Many associations utilize abstract management systems to organize the complicated process of executing successful scholarly meetings. In this paper, Thomson Reuters outlines easily implemented best practices designed to speed time to acceptance, decrease staff and volunteer time, improve communication, and create an exceptional meeting experience for speakers, attendees and members.
“Organizations do not necessarily need a large budget or endless resources to present a best-in-class meeting. What’s most important is how these resources are utilized and allocated,” said Keith MacGregor, executive vice president at Thomson Reuters. “Thomson Reuters has identified practical methods for organizations to host successful scholarly meetings through the use of our ScholarOne solutions.”

ScholarOne Abstracts and related meetings services offer organizations robust reporting and planning support for easier strategic decision-making on future conferences and provide users with the ability to stay ahead of the competition by extending valuable meeting content. ScholarOne Abstracts is the industry’s foremost technology for abstract management, enabling an efficient workflow solution that accelerates abstract acceptance and supports the leading research presentations at scholarly meetings and conferences.

ScholarOne ProceeedingsTM and ScholarOne Meeting ServicesTMare planning capabilities that compliment ScholarOne Abstracts by providing the most effective tools and strategies for meeting management. ScholarOne Proceedings provides a secure, cost-effective, end-to-end online solution for abstract and multi-phase proceedings submission, multiple review cycles, production output, and administrative control. ScholarOne Meeting Services offers an array of meeting solutions that complement the abstract including support tools that simplify the planning process to onsite promotion and content delivery.

To learn more about the capabilities within ScholarOne visit: http://scholarone.com/.

The IP & Science business of Thomson Reuters, the world’s leading provider of intelligent information for businesses and professionals, today announced a preview of its newest intelligence solution, Thomson Reuters Cortellis™ for Clinical Trials Intelligence. Scheduled for release in early 2013, this capability will provide drug development and clinical professionals with the critical information necessary to evaluate market opportunities, identify potential barriers, and establish informed decisions about clinical trial design and operations.

Cortellis for Clinical Trials Intelligence is the latest information solution offered through Thomson Reuters Cortellis, the industry’s premier Life Sciences information delivery platform. It has the broadest remit of any clinical trials database including a 45-year history of clinical outcomes, as well as the latest market competitive activity from established and emerging markets such as China, India and Brazil. It is the only solution that enables a customer to integrate their proprietary research data with comprehensive clinical trials protocols and outcomes, drug pipeline, biomarker, regulatory, financial and patent information from Thomson Reuters. Users will be able to extract more value from clinical trial data by utilizing the built-in analytics and visualizations, which can aid in strategic planning and decision-making, particularly for drug detox centers in LA where they can check the drug’s effect on patients.

“Cortellis for Clinical Trials Intelligence provides comprehensive clinical trial protocols and outcomes with global reach and integrates with other key intelligence areas – such as patents and literature – to allow for the broadest possible perspectives and actionable insights,” said Jon Brett-Harris, executive vice president at Thomson Reuters. “However, it is not just an information web portal. We are also providing multiple delivery options, such as dynamic real-time visualizations, iPad support and application programming interfaces to assist our customers in integrating it with their existing knowledge platforms and workflow solutions.”

Cortellis for Clinical Trials Intelligence optimizes critical clinical trial functions by equipping R&D strategists with knowledge that helps them discover market opportunities and potential barriers. This solution enables efficient searching for competing trials as well as identifying countries rich in target populations. By empowering clinical development teams to better understand trial design trends, Cortellis for Clinical Trials Intelligence allows them to design better and faster trials, while enabling marketing teams to pinpoint likely competitors.

The experts of Thomson Reuters’ professional services also utilize Cortellis for Clinical Trial Intelligence and the company’s other intelligence solutions – including translational medicine offerings and clinical development and portfolio strategy benchmarking – to support specific customer projects. Thomson Reuters has more than 15 years of experience supporting clinical development in the optimization of global clinical performance metrics, analysis and trending through its business, CMR International.

For more information on Cortellis, visit cortellis.thomsonreuters.com.

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today the appointment of Christian Hartman, PharmD, MBA, FSMSO, as Director of Clinical Quality and Patient Safety for Pharmacy OneSource. In this role, Hartman is responsible for ensuring the optimal use and development of electronic clinical surveillance and quality improvement solutions.
“Dr. Hartman is an expert in the field of medication safety and has the knowledge and expertise necessary to support our team in the development and advancement of clinical surveillance and quality improvement solutions,” said Tim Gibbons, Vice President & General Manager, Pharmacy OneSource, Wolters Kluwer Health Clinical Solutions.

Dr. Hartman is founder and president of the American Society of Medication Safety Officers, a professional organization representing medication safety officers at healthcare organizations. He is also an assistant professor of medicine and nursing at the University of Massachusetts Medical School, an adjunct professor of pharmacy practice at the Massachusetts College of Pharmacy and Health Sciences and the University of Rhode Island, and a clinical assistant professor of pharmacy practice at Northeastern University.

Recently, Dr. Hartman was appointed to chair a Special Commission to enhance oversight of Massachusetts’ pharmacy compounding industry. The Special Commission was created in the wake of a fatal fungal meningitis outbreak that was traced back to a Massachusetts-based compounding pharmacy.

Prior to joining Pharmacy OneSource, Dr. Hartman served as a senior research pharmacist at Brigham and Women’s Hospital in Boston. Previously, he was the first Medication Safety Officer at UMass Memorial Medical Center in Worcester, Mass., where he created the first accredited post-doctoral residency program in medication safety. During his tenure, UMass had three successful Joint Commission accreditation visits with no medication management RFIs. Dr. Hartman also converted the organization to electronic error reporting, increased error reporting by 150% and created an electronic solution to detect potential adverse drug events using the IHI Global Trigger tool and IHI 5 Million Lives: Preventing Harm from High Alert Medications.

Dr. Hartman received his bachelor’s degree in pharmacy from the Massachusetts College of Pharmacy in Boston and Doctorate from the University of Kansas. He completed a fellowship in patient safety at the Virginia Commonwealth University and holds an MBA from the Isenberg School of Management at UMass-Amherst.

Dr. Hartman has served as the president of Massachusetts Society of Health-System Pharmacists (MSHP) and MSHP Foundation, the ASHP Section Advisory Group for Medication Safety, ASHP Section Advisory Group for Compliance and Quality, and University HealthSystem Consortium Pharmacy Council Committee for Medication Use and Technology. Dr. Hartman is a Fellow of the American Society of Medication Safety Officers and currently serves on the Advisory Board to Decision Health Medication Management Error Elimination.

With government policy-makers and private funding agencies in the US, UK and Europe mandating greater public access to published scientific research, Copyright Clearance Center, Inc. (CCC), a not-for-profit organization and leading provider of licensing and content solutions, announced it endorses the Research Information Network’s call for cooperation among funders, universities, and publishers. CCC has been helping publishers improve the author experience with respect to the collection of article processing charges for over five years, and welcomes efforts towards standardization and transparency.

The UK-based Research Information Network (RIN) issued a report last week urging stakeholders to “work together to ensure that progress … is as smooth as possible toward creating the systems and processes that enable the payment of ‘Open Access’ article processing charges (APCs), while meeting the costs of publication.” The Wellcome Trust and Joint Information Systems Committee (JISC) commissioned the RIN study on behalf of the Open Access Implementation Group. In the paper, author Michael Jubb specifically identified several “core” functionalities that publishers and funders should require of any APC solution.

“Mr. Jubb has delivered a straight-forward action plan for publishers and funders at a critical moment in the evolution of Open Access publishing,” said Roy Kaufman, Managing Director of New Ventures, CCC. “We have extensive experience helping publishers manage a range of OA models through our RightsLink® platform, and already provide the “core” functionalities identified in the report. Our results demonstrate that publishers can encourage compliance with funding agency requirements even as they implement customized pricing rules,
licenses and messaging for their OA journals and other works. This is precisely where Jubb places his most emphatic concern – on facilitating and standardizing workflow among authors, publishers, funders and universities.”

CCC’s Open Access Solutions include secure tools for managing author publication charges, as well as color charges, page charges and reprint orders. RightsLink users have 24/7 access to these tools, including reporting and customer service.